Cargando…

Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats

Cerebrolysin (CBL), a mixture of several active peptide fragments and neurotrophic factors including brain-derived neurotrophic factor (BDNF), is currently used in the management of cognitive alterations in patients with dementia. Since Cognitive decline as well as increased dementia are strongly as...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgy, Gehan S., Nassar, Noha N., Mansour, Hanaa A., Abdallah, Dalaal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686810/
https://www.ncbi.nlm.nih.gov/pubmed/23840309
http://dx.doi.org/10.1371/journal.pone.0064847
_version_ 1782273844439941120
author Georgy, Gehan S.
Nassar, Noha N.
Mansour, Hanaa A.
Abdallah, Dalaal M.
author_facet Georgy, Gehan S.
Nassar, Noha N.
Mansour, Hanaa A.
Abdallah, Dalaal M.
author_sort Georgy, Gehan S.
collection PubMed
description Cerebrolysin (CBL), a mixture of several active peptide fragments and neurotrophic factors including brain-derived neurotrophic factor (BDNF), is currently used in the management of cognitive alterations in patients with dementia. Since Cognitive decline as well as increased dementia are strongly associated with diabetes and previous studies addressed the protective effect of BDNF in metabolic syndrome and type 2 diabetes; hence this work aimed to evaluate the potential neuroprotective effect of CBL in modulating the complications of hyperglycaemia experimentally induced by streptozotocin (STZ) on the rat brain hippocampus. To this end, male adult Sprague Dawley rats were divided into (i) vehicle- (ii) CBL- and (iii) STZ diabetic-control as well as (iv) STZ+CBL groups. Diabetes was confirmed by hyperglycemia and elevated glycated haemoglobin (HbA1c%), which were associated by weight loss, elevated tumor necrosis factor (TNF)-α and decreased insulin growth factor (IGF)-1β in the serum. Uncontrolled hyperglycemia caused learning and memory impairments that corroborated degenerative changes, neuronal loss and expression of caspase (Casp)-3 in the hippocampal area of STZ-diabetic rats. Behavioral deficits were associated by decreased hippocampal glutamate (GLU), glycine, serotonin (5-HT) and dopamine. Moreover, diabetic rats showed an increase in hippocampal nitric oxide and thiobarbituric acid reactive substances versus decreased non-protein sulfhydryls. Though CBL did not affect STZ-induced hyperglycemia, it partly improved body weight as well as HbA1c%. Such effects were associated by enhancement in both learning and memory as well as apparent normal cellularity in CA1and CA3 areas and reduced Casp-3 expression. CBL improved serum TNF-α and IGF-1β, GLU and 5-HT as well as hampering oxidative biomarkers. In conclusion, CBL possesses neuroprotection against diabetes-associated cerebral neurodegeneration and cognitive decline via anti-inflammatory, antioxidant and antiapototic effects.
format Online
Article
Text
id pubmed-3686810
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36868102013-07-09 Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats Georgy, Gehan S. Nassar, Noha N. Mansour, Hanaa A. Abdallah, Dalaal M. PLoS One Research Article Cerebrolysin (CBL), a mixture of several active peptide fragments and neurotrophic factors including brain-derived neurotrophic factor (BDNF), is currently used in the management of cognitive alterations in patients with dementia. Since Cognitive decline as well as increased dementia are strongly associated with diabetes and previous studies addressed the protective effect of BDNF in metabolic syndrome and type 2 diabetes; hence this work aimed to evaluate the potential neuroprotective effect of CBL in modulating the complications of hyperglycaemia experimentally induced by streptozotocin (STZ) on the rat brain hippocampus. To this end, male adult Sprague Dawley rats were divided into (i) vehicle- (ii) CBL- and (iii) STZ diabetic-control as well as (iv) STZ+CBL groups. Diabetes was confirmed by hyperglycemia and elevated glycated haemoglobin (HbA1c%), which were associated by weight loss, elevated tumor necrosis factor (TNF)-α and decreased insulin growth factor (IGF)-1β in the serum. Uncontrolled hyperglycemia caused learning and memory impairments that corroborated degenerative changes, neuronal loss and expression of caspase (Casp)-3 in the hippocampal area of STZ-diabetic rats. Behavioral deficits were associated by decreased hippocampal glutamate (GLU), glycine, serotonin (5-HT) and dopamine. Moreover, diabetic rats showed an increase in hippocampal nitric oxide and thiobarbituric acid reactive substances versus decreased non-protein sulfhydryls. Though CBL did not affect STZ-induced hyperglycemia, it partly improved body weight as well as HbA1c%. Such effects were associated by enhancement in both learning and memory as well as apparent normal cellularity in CA1and CA3 areas and reduced Casp-3 expression. CBL improved serum TNF-α and IGF-1β, GLU and 5-HT as well as hampering oxidative biomarkers. In conclusion, CBL possesses neuroprotection against diabetes-associated cerebral neurodegeneration and cognitive decline via anti-inflammatory, antioxidant and antiapototic effects. Public Library of Science 2013-06-19 /pmc/articles/PMC3686810/ /pubmed/23840309 http://dx.doi.org/10.1371/journal.pone.0064847 Text en © 2013 Georgy et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Georgy, Gehan S.
Nassar, Noha N.
Mansour, Hanaa A.
Abdallah, Dalaal M.
Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
title Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
title_full Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
title_fullStr Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
title_full_unstemmed Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
title_short Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
title_sort cerebrolysin ameloriates cognitive deficits in type iii diabetic rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686810/
https://www.ncbi.nlm.nih.gov/pubmed/23840309
http://dx.doi.org/10.1371/journal.pone.0064847
work_keys_str_mv AT georgygehans cerebrolysinameloriatescognitivedeficitsintypeiiidiabeticrats
AT nassarnohan cerebrolysinameloriatescognitivedeficitsintypeiiidiabeticrats
AT mansourhanaaa cerebrolysinameloriatescognitivedeficitsintypeiiidiabeticrats
AT abdallahdalaalm cerebrolysinameloriatescognitivedeficitsintypeiiidiabeticrats